Hyperuricemia and coronary heart disease: a systematic review and meta-analysis
- PMID: 20191515
- PMCID: PMC3156692
- DOI: 10.1002/acr.20065
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis
Abstract
Objective: The role of serum uric acid as an independent risk factor for cardiovascular disease remains unclear, although hyperuricemia is associated with cardiovascular disease such as coronary heart disease (CHD), stroke, and hypertension.
Methods: A systematic review and meta-analysis using a random-effects model was conducted to determine the risk of CHD associated with hyperuricemia in adults. Studies of hyperuricemia and CHD were identified by searching major electronic databases using the medical subject headings and keywords without language restriction (through February 2009). Only prospective cohort studies were included if they had data on CHD incidences or mortalities related to serum uric acid levels in adults.
Results: Twenty-six eligible studies of 402,997 adults were identified. Hyperuricemia was associated with an increased risk of CHD incidence (unadjusted risk ratio [RR] 1.34, 95% confidence interval [95% CI] 1.19-1.49) and mortality (unadjusted RR 1.46, 95% CI 1.20-1.73). When adjusted for potential confounding, the pooled RR was 1.09 (95% CI 1.03-1.16) for CHD incidence and 1.16 (95% CI 1.01-1.30) for CHD mortality. For each increase of 1 mg/dl in uric acid level, the pooled multivariate RR for CHD mortality was 1.12 (95% CI 1.05-1.19). Subgroup analyses showed no significant association between hyperuricemia and CHD incidence/mortality in men, but an increased risk for CHD mortality in women (RR 1.67, 95% CI 1.30-2.04).
Conclusion: Hyperuricemia may marginally increase the risk of CHD events, independently of traditional CHD risk factors. A more pronounced increased risk for CHD mortality in women should be investigated in future research.
Conflict of interest statement
Financial supports or conflicts disclosure:
- S Kim: NIH T32 (AR 055885 and AR 007442-22)
- HK Choi: Holds the Mary Pack Arthritis Society of Canada Chair in Rheumatology, served on the advisory board for TAP and Savient Pharmaceuticals
- JP Guevara, K Kim, DF Heitjan and DA Albert – None
Figures




Similar articles
-
Patient education in the management of coronary heart disease.Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD008895. doi: 10.1002/14651858.CD008895.pub3. Cochrane Database Syst Rev. 2017. PMID: 28658719 Free PMC article.
-
Hyperuricemia and risk of stroke: a systematic review and meta-analysis.Arthritis Rheum. 2009 Jul 15;61(7):885-92. doi: 10.1002/art.24612. Arthritis Rheum. 2009. PMID: 19565556 Free PMC article.
-
Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis.Clin Chem Lab Med. 2016 Jan;54(1):7-15. doi: 10.1515/cclm-2015-0523. Clin Chem Lab Med. 2016. PMID: 26351943
-
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280. Health Technol Assess. 2008. PMID: 18547499
-
Exercise-based cardiac rehabilitation for coronary heart disease.Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2021 Nov 6;11:CD001800. doi: 10.1002/14651858.CD001800.pub4. PMID: 26730878 Free PMC article. Updated.
Cited by
-
Association between Serum Uric Acid Levels and Sleep Variables: Results from the National Health and Nutrition Survey 2005-2008.Int J Inflam. 2012;2012:363054. doi: 10.1155/2012/363054. Epub 2012 Aug 28. Int J Inflam. 2012. PMID: 22970407 Free PMC article.
-
Relationship between Hyperuricemia and Haar-Like Features on Tongue Images.Biomed Res Int. 2015;2015:363216. doi: 10.1155/2015/363216. Epub 2015 Apr 15. Biomed Res Int. 2015. PMID: 25961013 Free PMC article.
-
Severe cutaneous reactions requiring hospitalization in allopurinol initiators: a population-based cohort study.Arthritis Care Res (Hoboken). 2013 Apr;65(4):578-84. doi: 10.1002/acr.21817. Arthritis Care Res (Hoboken). 2013. PMID: 22899369 Free PMC article.
-
Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.Semin Nephrol. 2020 Nov;40(6):574-585. doi: 10.1016/j.semnephrol.2020.12.004. Semin Nephrol. 2020. PMID: 33678312 Free PMC article. Review.
-
Relationship between Plasma Pentraxin-3, Neutrophil-to-Lymphocyte Ratio, and Atherosclerosis in Renal Transplant Patients.Cardiorenal Med. 2012 Dec;2(4):298-307. doi: 10.1159/000343887. Epub 2012 Nov 16. Cardiorenal Med. 2012. PMID: 23380985 Free PMC article.
References
-
- Wu X, Muzny D, Lee C, Caskey C. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol. 1992;34(1):78–84. - PubMed
-
- Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol. 2002;19(5):640–53. - PubMed
-
- Baker J, Krishnan E, Chen L, Schumacher H. Serum uric acid and cardiovascular disease: recent developments, where do they leave us? Am J Med. 2005;118:816–26. - PubMed
-
- Becker M, Jolly M. Hyperuricemia and associated diseases. Rheum Dis Clin N Am. 2006;32:275–93. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources